Response to the Letter to the Editor Regarding "Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials"

J Clin Immunol. 2017 Nov;37(8):739-740. doi: 10.1007/s10875-017-0438-y. Epub 2017 Sep 5.

¹ Allergy, Asthma and Immunology Clinic PA, Irving, TX, USA.
² Allergy Associates of the Palm Beaches, North Palm Beach, FL, USA.
³ Division of Basic and Clinical Immunology, University of California at Irvine, Irvine, CA, USA.
⁴ Vital Prospects Clinical Research Institute, Tulsa, OK, USA.
⁵ IMMUNOe International Research Centers, Centennial, CO, USA.
⁶ LSU Health Sciences Center, Children's Hospital, New Orleans, LA, USA.
⁷ Oklahoma Institute of Allergy and Asthma Clinical Research, LLC, Oklahoma City, OK, USA.
⁸ Shire, Vienna, Austria.
⁹ Shire, Cambridge, MA, USA.
¹⁰ Shire, Westlake Village, CA, USA.
¹¹ Shire, Cambridge, MA, USA. leman.yel@shire.com.

No abstract available

Publication types